Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:37 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–65 of 65 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Autologous Platelet-Rich Plasma (PRP) Injection Clear all

Conditions: Plantar Fasciitis
Interventions: platelet rich plasma, corticosteroid injection; Biological · Drug
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 89 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: San Bernadino, California

Conditions: Lateral Epicondylitis (Tennis Elbow)
Interventions: Platelet Rich Plasma (PRP) Injection, Whole Blood Injection, Dry Needle Fenestration, Sham Injection; Other
Lead sponsor: McMaster University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2023
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Alopecia
Interventions: Platelet Rich Plasma, Minoxidil Foam; Other · Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Frontal Fibrosing Alopecia
Interventions: Eclipse Easy Spin for PRP; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Chronic Patellar Tendinopathy, Chronic PT
Interventions: platelet rich plasma, saline; Biological · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2024
U.S. locations: 2
States / cities: Madison, Wisconsin

Conditions: Tennis Elbow
Interventions: Dextrose prolotherapy, PrT-DMS, Platelet Rich Plasma injection; Procedure
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 65 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 2
States / cities: Madison, Wisconsin

Conditions: Perimenopausal Disorder, Menopause, Menopause, Premature, Menopause Related Conditions, Menopause Premature Symptomatic, Menopause Premature Asymptomatic, Premature Ovarian Failure, Premature Ovarian Failure, Familial, Premature Ovarian Failure 2A, Premature Ovarian Failure 3, Premature Ovarian Failure 4, Premature Ovarian Failure 1, Premature Ovarian Failure 5, Premature Ovarian Failure 6, Premature Ovarian Failure 7, Premature Ovarian Failure 9, Premature Ovarian Failure 8, Infertility, Infertility, Female, Infertility Unexplained
Interventions: Autologous PRP injection into human ovarian tissue; Other
Lead sponsor: Ascendance Biomedical; Industry
Eligibility: 35 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Carlsbad, California

Conditions: Partial Tear of Rotator Cuff, Tendinopathy of Rotator Cuff
Interventions: PRP injection into PTRCT, Subacromial steroid bursal injection; Procedure · Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years to 75 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Achilles Tendinitis
Interventions: Autologous Platelet Rich Plasma, Ultrasound Imaging, Quality of Life Questionnaires; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Vulvar Lichen Sclerosus
Interventions: Autologous Platelet-Rich Plasma (PRP), Sham Procedure; Biological · Other
Lead sponsor: Jennifer R. Arthurs; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Breast Adenocarcinoma, Genitourinary Syndrome of Menopause, Prognostic Stage 0 Breast Cancer AJCC v8, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8
Interventions: Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Autologous Platelet-rich Plasma; Other · Biological
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Achilles Injuries Tendon, Achilles Tendinopathy (AT), Achilles Tendinitis, Left Leg, Achilles Tendinitis, Right Leg, Achilles Tendon Pain, Achilles Tendonitis
Interventions: Platelet Rich Plasma, Extracorporeal Shockwave Therapy, Sham PRP, Sham ESWT; Device
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Osteoarthritis
Interventions: [StroMed + platelet rich plasma (PRP)]; Biological
Lead sponsor: VivaTech International, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 4,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2026
U.S. locations: 1
States / cities: Grove City, Pennsylvania

Conditions: Diminished Ovarian Reserve, Ovarian Failure
Interventions: A-PRP; Procedure
Lead sponsor: Center for Human Reproduction; Other
Eligibility: 21 Years to 52 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Knee Osteoarthritis
Interventions: PRP Treatment, HA Treatment; Biological
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Skokie, Illinois

Conditions: Hip Osteoarthritis
Interventions: Platelet Rich Plasma Joint Injection, Corticosteroid Injection; Device · Drug
Lead sponsor: LifeBridge Health; Other
Eligibility: 21 Years to 80 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Osteoarthritis, OA, Knee Osteoarthritis
Interventions: Autologous Alpha-2 Macroglobulin Rich Plasma (A2MRP); Biological
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

Treatment of Plantar Fasciitis With Platelet Rich Plasma

Comparison of Platelet Rich Plasma and Alternative Therapies for the Treatment of Tennis Elbow (Lateral Epicondylitis)

Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women

Platelet Rich Plasma for Frontal Fibrosing Alopecia

Platelet-Rich Plasma (PRP) Injection for the Treatment of Chronic Patellar Tendinopathy

Efficacy of Injection Therapy for Lateral Epicondylosis

Inovium Ovarian Rejuvenation Trials

Non-Surgical Treatment for Rotator-Cuff Tears Using Platelet-Rich-Plasma

A Pilot Study: Treatment of Achilles Tendinopathy With Platelet-Rich Plasma Therapy

A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus

Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancer

Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Hip

Study of PRP in Women With Evidence of Diminished Ovarian Reserve

Intra-articular Platelet-Rich Plasma Compared With Viscosupplementation in the Treatment of Knee Osteoarthritis

Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain

Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis